Quiet
corners of the law, like unjust enrichment and its gain-based restitution
remedies, often hold the only viable path to recovery. This panel explores
unjust enrichment’s potential in ongoing federal litigation, In re
Henrietta Lacks Estate. The Lacks Estate sued a large biotech company,
Thermo Fisher, alleging unjust profits from continued use of Henrietta Lacks’s
immortal cells, HeLa cells, without consent. This panel includes experts in
unjust enrichment, public health, critical race and feminism, and history, as
well as counsel and amici. Panelists examine racial, historical, and legal
frames to determine whether the Lacks heirs deserve to disgorge unjust gains.